Surfactant for Neonatal Respiratory Distress Syndrome at High Altitude Areas:a Prospective Cohort Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03479450|
Recruitment Status : Not yet recruiting
First Posted : March 27, 2018
Last Update Posted : March 27, 2018
|Condition or disease||Intervention/treatment|
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Surfactant for Neonatal Respiratory Distress Syndrome at High Altitude Areas:a Prospective Cohort Study|
|Estimated Study Start Date :||October 1, 2018|
|Estimated Primary Completion Date :||October 1, 2020|
|Estimated Study Completion Date :||October 1, 2020|
- Drug: surfactant
surfactant is given when neonatal respiratory distress syndrome is diagnosed
- the intubation rate [ Time Frame: one week ]to describe how many neonates might be intubated.
- the effect of surfactant for neonatal respiratory distress syndrome(NRDS) [ Time Frame: one week ]to describe the effect of surfactant for NRDS in high altitude areas.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03479450
|Contact: Ma Juan, MDfirstname.lastname@example.org|
|Contact: Chen Long, PhD,MDemail@example.com|
|Department of Pediatrics, Daping Hospital, Third Military Medical University|
|Chongqing, Chongqing, China, 400042|